Centrose
PrivateLast Round
Early Funding
Jan 24, 2014
Total Funding Raised
$1.28M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Centrose is a biotechnology company that develops Extracellular Drug Conjugates (EDCs) for targeted cancer therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Centrose Comparables
Compare Centrose with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BlinkBio, Inc. | 79% | |
| Tagworks Pharmaceuticals | 77% | |
| Adcentrx Therapeutics | 76% |
Centrose Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jan 24, 2014 | ||||
| Grant | Jun 27, 2007 |
Centrose Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 300% MoM, reaching 1.8K.
- Apr 1, 2026
Monthly visitors grew 749% MoM, from 141 to 1.2K.
Centrose Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Centrose's valuation, stock price, and market status.
Is Centrose a public or private company?
Centrose is a private company.
What is the current stock price of Centrose?
Centrose is a private company, so its shares have no public market price. Caplight tracks Centrose's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Centrose worth (valuation)?
Valuation information for Centrose is not publicly available.
Can I buy Centrose stock?
Centrose shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Centrose's last funding round?
Centrose's most recent funding round was Early Funding on January 24, 2014.
Who are the main investors in Centrose?
Key investors in Centrose include National Institute of Allergy and Infectious Diseases.
Will Centrose IPO soon?
No public IPO plans have been announced for Centrose.
How can I track Centrose secondary market activity?
Caplight tracks bids, offers, and trades in Centrose's shares on secondary markets.